Quinolinic acid, a kynurenine/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus
Guardado en:
Autores principales: | Richard A Furie, Meggan Mackay, Betty Diamond, Bruce T Volpe, Erik W Anderson, Joanna Fishbein, Joseph Hong, Julien Roeser |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4be6186886f74cca978ea481eedc17f7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum profiles of tryptophan-kynurenine pathway metabolites in psoriasis
por: Mariko Seishima, et al.
Publicado: (2021) -
Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain.
por: Wei Wu, et al.
Publicado: (2013) -
Tryptophan, kynurenine pathway, and diabetic ketoacidosis in type 1 diabetes.
por: William H Hoffman, et al.
Publicado: (2021) -
Circulating concentrations of citrulline, neopterin, kynurenine, and tryptophan during chemoradiation in patients with cervical carcinoma
por: Pospíšková Markéta, et al.
Publicado: (2021) -
Moulage: "Lupus Erythematosus"
por: Beatrix Patzak
Publicado: (2011)